Group One Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
25,717
-4,063
| -14% | -$217K | ﹤0.01% | 420 |
|
|
2025
Q1 | $1.21M | Buy |
+29,780
| New | +$1.21M | ﹤0.01% | 365 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2052 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1726 |
|
|
2024
Q2 | – | Sell |
-2,416
| Closed | -$61K | – | 1753 |
|
|
2024
Q1 | $61K | Sell |
2,416
-35,455
| -94% | -$896K | ﹤0.01% | 914 |
|
|
2023
Q4 | $884K | Buy |
37,871
+12,853
| +51% | +$300K | ﹤0.01% | 407 |
|
|
2023
Q3 | $1.27M | Sell |
25,018
-55,546
| -69% | -$2.81M | ﹤0.01% | 335 |
|
|
2023
Q2 | $3.76M | Buy |
80,564
+80,417
| +54,705% | +$3.75M | 0.01% | 133 |
|
|
2023
Q1 | $5.62K | Sell |
147
-124,481
| -100% | -$4.76M | ﹤0.01% | 1424 |
|
|
2022
Q4 | $6.83M | Buy |
124,628
+124,573
| +226,496% | +$6.83M | 0.02% | 102 |
|
|
2022
Q3 | $2K | Sell |
55
-745
| -93% | -$27.1K | ﹤0.01% | 1786 |
|
|
2022
Q2 | $8K | Sell |
800
-8,600
| -91% | -$86K | ﹤0.01% | 1681 |
|
|
2022
Q1 | $133K | Buy |
+9,400
| New | +$133K | ﹤0.01% | 1160 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2155 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2061 |
|
|
2021
Q2 | – | Sell |
-43,885
| Closed | -$1.27M | – | 1987 |
|
|
2021
Q1 | $1.27M | Buy |
43,885
+43,819
| +66,392% | +$1.27M | ﹤0.01% | 486 |
|
|
2020
Q4 | $2K | Hold |
66
| – | – | ﹤0.01% | 1537 |
|
|
2020
Q3 | $2K | Sell |
66
-2,138
| -97% | -$64.8K | ﹤0.01% | 1427 |
|
|
2020
Q2 | $55K | Sell |
2,204
-1,237
| -36% | -$30.9K | ﹤0.01% | 907 |
|
|
2020
Q1 | $73K | Buy |
+3,441
| New | +$73K | ﹤0.01% | 758 |
|